Related Experiment Video

Updated: May 11, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study

V Calvo-Río1, J Loricera, L Martín

  • 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain.

Clinical and Experimental Rheumatology
|May 14, 2013
PubMed

Insights

Henoch-Schönlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) are distinct conditions. IgAN patients experienced more severe kidney problems, whereas HSPN presented with more symptoms outside the kidneys.

Area of Science:

  • Nephrology
  • Immunology
  • Pediatrics

Background:

  • Henoch-Schönlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) are related glomerular diseases.
  • Understanding their distinct clinical characteristics and long-term outcomes is crucial for patient management.

Purpose of the Study:

  • To compare the clinical features and outcomes of a large, unselected cohort of patients diagnosed with HSPN and IgAN.
  • To elucidate the differences in disease severity and extra-renal manifestations between HSPN and IgAN.

Main Methods:

  • A comparative study involving 142 patients with HSPN and 61 patients with IgAN from a Northern Spain teaching hospital.
  • Analysis of clinical characteristics, precipitating events, extra-renal manifestations, renal involvement severity, laboratory findings, treatment modalities, and long-term renal outcomes.

Main Results:

  • HSPN patients were younger and more frequently presented with precipitating events (infections, drug intake) and extra-renal symptoms (skin, gastrointestinal, joint involvement).
  • Nephritis was less severe in HSPN, with lower rates of renal insufficiency, nephrotic syndrome, and nephritic syndrome compared to IgAN.
  • IgAN patients showed significantly higher rates of renal insufficiency, nephrotic syndrome, and a greater need for dialysis and renal transplant during follow-up.

Conclusions:

  • HSPN and IgAN represent distinct clinical syndromes with differing primary manifestations.
  • IgAN is associated with more severe renal involvement and poorer long-term renal outcomes compared to HSPN.
  • HSPN is characterized by a higher prevalence of extra-renal manifestations, while IgAN predominantly affects the kidneys.
Abstract

More Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...